Both in Pharmaceuticals
Tvardi Therapeutics vs Cellectar Biosciences INC NEW
Over the past year TVRD returned −96.5% and CLRB returned −66.4%; their daily moves had a correlation of -0.03.
TVRD −96.5% CLRB −66.4%Growth of $1, one year, split-adjusted
| Metric | TVRD | CLRB |
|---|---|---|
| Price | $1.28 | $1.82 |
| Market cap | $17.1M | $17.2M |
| Today | −3.76% | −0.55% |
| 1 month | −29.7% | −28.1% |
| 6 months | −60.0% | −30.3% |
| Year to date | −70.2% | −38.3% |
| 1 year | −96.5% | −67.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $15.8M | $34.0M |
| Dividend yield | — | — |
| Volatility (60d) | 172.8% | 46.2% |
| Short % of float | 4.7% | 2.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).